{"transactions":[{"id":2442678,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":131603,"kind":"person","name":"Dominy Stephen S.","position":1,"cik":"0001770860","reported_name":"Dominy Stephen S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T21:53:10.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of the date of grant, such that the total number of shares shall be fully vested on the four-year anniversary of the date of grant."}],"balance_after":125000,"derivative":{"exercise_price":13.39,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-001754","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919122001754/doc4.xml","form_type":"4"}},{"id":2514232,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":131603,"kind":"person","name":"Dominy Stephen S.","position":1,"cik":"0001770860","reported_name":"Dominy Stephen S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-12T23:47:09.000Z","date":"2021-11-12","kind":"purchase","acquired":true,"shares":763,"price":14.4,"value":10987.2,"ownership":{"direct":false,"nature":"By the Dominy Family Trust 2016"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Stephen S. Dominy is a trustee of the Dominy Family Trust 2016, and shares voting and dispositive power with one other trustee with respect to the shares held of record by the Dominy Family Trust 2016."}],"balance_after":1217086,"source":{"system":"sec-edgar","filing":"0001209191-21-064346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919121064346/doc4.xml","form_type":"4"}},{"id":2943964,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":131603,"kind":"person","name":"Dominy Stephen S.","position":1,"cik":"0001770860","reported_name":"Dominy Stephen S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-16T00:07:04.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% of the shares will vest on March 31, 2023 provided that the Issuer's Compensation Committee has determined that Performance Condition No. 1 (as defined below) has been met, and 50% of the shares will vest on March 31, 2024 provided that the Issuer's Compensation Committee has determined that Performance Condition No. 2 (as defined below) has been met; provided further that, in each case, the grantee will have been continuously a service provider from the date of grant through each such vesting date. Performance Condition No. 1 means that the average closing price per share of the Issuer's common stock in any 45 consecutive trading day period prior to March 15, 2023 has exceeded $135 per share. Performance Condition No. 2 means that the average closing price per share of the Issuer's common stock in any 45 consecutive trading day period prior to March 15, 2024 has exceeded $170 per share."}],"balance_after":100000,"derivative":{"exercise_price":29.6,"expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-063602","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120063602/doc4.xml","form_type":"4"}},{"id":2943963,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":131603,"kind":"person","name":"Dominy Stephen S.","position":1,"cik":"0001770860","reported_name":"Dominy Stephen S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-16T00:07:04.000Z","date":"2020-12-11","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 48 equal monthly installments from the vesting commencement date, subject to the grantee's continuous service to the Issuer on each such date."}],"balance_after":100000,"derivative":{"exercise_price":29.6,"expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-063602","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120063602/doc4.xml","form_type":"4"}},{"id":3281517,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":131603,"kind":"person","name":"Dominy Stephen S.","position":1,"cik":"0001770860","reported_name":"Dominy Stephen S.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-10T23:12:12.000Z","date":"2020-02-06","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest and become exercisable monthly over four years."}],"balance_after":100000,"derivative":{"exercise_price":54.85,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-008068","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919120008068/doc4.xml","form_type":"4"}}]}